Pfizer to Hire Amy Schulman as Next General Counsel

Amy Schulman, who heads the mass tort/class action practice at DLA Piper, will be the next general counsel at Pfizer.   Ms. Schulman lead the Celebrex and Bextra litigations for Pfizer (see WSJ blog and article), and was also the subject of a Harvard Business School case study entitled, Leadership in Law: Amy Schulman at DLA Piper.  For more, see this post from AmLaw Daily.

BGS